Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-26-001491

Options or other derivatives

  • Chief Technology Officer acquired 9,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Faulkner Eric · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-02 Grant or award : show line 1 in the form Restricted Stock Units +9,500 9,500 D
Loading xslF345X05/ownership.xml…